BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31002890)

  • 1. Inactivation of Rab27B-dependent signaling pathway by calycosin inhibits migration and invasion of ER-negative breast cancer cells.
    Wu G; Niu M; Qin J; Wang Y; Tian J
    Gene; 2019 Aug; 709():48-55. PubMed ID: 31002890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.
    Tian J; Wang Y; Zhang X; Ren Q; Li R; Huang Y; Lu H; Chen J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):153. PubMed ID: 29096683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis.
    Hendrix A; Maynard D; Pauwels P; Braems G; Denys H; Van den Broecke R; Lambert J; Van Belle S; Cocquyt V; Gespach C; Bracke M; Seabra MC; Gahl WA; De Wever O; Westbroek W
    J Natl Cancer Inst; 2010 Jun; 102(12):866-80. PubMed ID: 20484105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
    Chen J; Hou R; Zhang X; Ye Y; Wang Y; Tian J
    PLoS One; 2014; 9(3):e91245. PubMed ID: 24618835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calycosin Inhibits the Migration and Invasion of Human Breast Cancer Cells by Down-Regulation of Foxp3 Expression.
    Li S; Wang Y; Feng C; Wu G; Ye Y; Tian J
    Cell Physiol Biochem; 2017; 44(5):1775-1784. PubMed ID: 29241196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin.
    Chen J; Zhao X; Ye Y; Wang Y; Tian J
    Cell Physiol Biochem; 2013; 32(6):1790-7. PubMed ID: 24355881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calycosin inhibits breast cancer cell migration and invasion by suppressing EMT via BATF/TGF-β1.
    Zhang Z; Lin M; Wang J; Yang F; Yang P; Liu Y; Chen Z; Zheng Y
    Aging (Albany NY); 2021 Jun; 13(12):16009-16023. PubMed ID: 34096887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The secretory small GTPase Rab27B as a marker for breast cancer progression.
    Hendrix A; Braems G; Bracke M; Seabra MC; Gahl WA; De Wever O; Westbroek W
    Oncotarget; 2010 Aug; 1(4):304-308. PubMed ID: 21304180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer.
    Hendrix A; Sormunen R; Westbroek W; Lambein K; Denys H; Sys G; Braems G; Van den Broecke R; Cocquyt V; Gespach C; Bracke M; De Wever O
    Int J Cancer; 2013 Aug; 133(4):843-54. PubMed ID: 23390068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of calycosin on breast cancer cell progression through downregulating lncRNA HOTAIR and downstream targets: HuR and IGF2BP1.
    Li Y; Miao H; Wei W; Tian J; Chen J
    Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 55(2):225-236. PubMed ID: 36647722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression.
    Roy A; Ansari SA; Das K; Prasad R; Bhattacharya A; Mallik S; Mukherjee A; Sen P
    J Biol Chem; 2017 Aug; 292(33):13688-13701. PubMed ID: 28522609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calycosin stimulates proliferation of estrogen receptor-positive human breast cancer cells through downregulation of Bax gene expression and upregulation of Bcl-2 gene expression at low concentrations.
    Chen J; Xiong WB; Xiong Y; Wu YY; Chen XJ; Shao ZJ; Liu LT; Kuang WJ; Tan XS; Zhou LM
    JPEN J Parenter Enteral Nutr; 2011 Nov; 35(6):763-9. PubMed ID: 21799188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-metastatic effects of the phytoestrogen arctigenin on human breast cancer cell lines regardless of the status of ER expression.
    Maxwell T; Chun SY; Lee KS; Kim S; Nam KS
    Int J Oncol; 2017 Feb; 50(2):727-735. PubMed ID: 28035371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
    Zhou R; Xu L; Ye M; Liao M; Du H; Chen H
    Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of RhoGDIα increased migration and invasion of ER (+) MCF7 and ER (-) MDA-MB-231 breast cancer cells.
    Hooshmand S; Ghaderi A; Yusoff K; Karrupiah T; Rosli R; Mojtahedi Z
    Cell Adh Migr; 2013; 7(3):297-303. PubMed ID: 23563506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
    Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
    Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.